| Title | International consensus statement on allergy and rhinology: rhinosinusitis 2021. |
| Publication Type | Journal Article |
| Year of Publication | 2021 |
| Authors | Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, Poetker DM, Soler Z, Welch KC, Wise SK, Adappa N, Alt JA, Anselmo-Lima WTerezinha, Bachert C, Baroody FM, Batra PS, Bernal-Sprekelsen M, Beswick D, Bhattacharyya N, Chandra RK, Chang EH, Chiu A, Chowdhury N, Citardi MJ, Cohen NA, Conley DB, DelGaudio J, Desrosiers M, Douglas R, Eloy JAnderson, Fokkens WJ, Gray ST, Gudis DA, Hamilos DL, Han JK, Harvey R, Hellings P, Holbrook EH, Hopkins C, Hwang P, Javer AR, San Jiang R-, Kennedy D, Kern R, Laidlaw T, Lal D, Lane A, Lee H-M, Lee JT, Levy JM, Lin SY, Lund V, McMains KC, Metson R, Mullol J, Naclerio R, Oakley G, Otori N, Palmer JN, Parikh SR, Passali D, Patel Z, Peters A, Philpott C, Psaltis AJ, Ramakrishnan VR, Ramanathan M, Roh H-J, Rudmik L, Sacks R, Schlosser RJ, Sedaghat AR, Senior BA, Sindwani R, Smith K, Snidvongs K, Stewart M, Suh JD, Tan BK, Turner JH, van Drunen CM, Voegels R, Wang DYun, Woodworth BA, Wormald P-J, Wright ED, Yan C, Zhang L, Zhou B |
| Journal | Int Forum Allergy Rhinol |
| Volume | 11 |
| Issue | 3 |
| Pagination | 213-739 |
| Date Published | 2021 03 |
| ISSN | 2042-6984 |
| Keywords | Consensus, Humans, Rhinitis, Rhinitis, Allergic, Sinusitis |
| Abstract | I. EXECUTIVE SUMMARY: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document. METHODS: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. RESULTS: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided. CONCLUSION: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS. |
| DOI | 10.1002/alr.22741 |
| Alternate Journal | Int Forum Allergy Rhinol |
| PubMed ID | 33236525 |
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
Faculty Reference:
Eugene H. Chang, MD